These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19266573)

  • 1. Activation of NOD2-mediated intestinal pathway in a pediatric population with Crohn's disease.
    Negroni A; Stronati L; Pierdomenico M; Tirindelli D; Di Nardo G; Mancini V; Maiella G; Cucchiara S
    Inflamm Bowel Dis; 2009 Aug; 15(8):1145-54. PubMed ID: 19266573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal NOD2 expression and NF-kappaB activation in pediatric Crohn's disease.
    Stronati L; Negroni A; Merola P; Pannone V; Borrelli O; Cirulli M; Annese V; Cucchiara S
    Inflamm Bowel Dis; 2008 Mar; 14(3):295-302. PubMed ID: 18092345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
    Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL
    Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dual role for receptor-interacting protein kinase 2 (RIP2) kinase activity in nucleotide-binding oligomerization domain 2 (NOD2)-dependent autophagy.
    Homer CR; Kabi A; Marina-García N; Sreekumar A; Nesvizhskii AI; Nickerson KP; Chinnaiyan AM; Nuñez G; McDonald C
    J Biol Chem; 2012 Jul; 287(30):25565-76. PubMed ID: 22665475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of human enteric α-defensins by NOD2 in the Paneth cell lineage.
    Tan G; Zeng B; Zhi FC
    Eur J Cell Biol; 2015 Jan; 94(1):60-6. PubMed ID: 25433720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways.
    Tao M; Scacheri PC; Marinis JM; Harhaj EW; Matesic LE; Abbott DW
    Curr Biol; 2009 Aug; 19(15):1255-63. PubMed ID: 19592251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1.
    Zhao Y; Alonso C; Ballester I; Song JH; Chang SY; Guleng B; Arihiro S; Murray PJ; Xavier R; Kobayashi KS; Reinecker HC
    Inflamm Bowel Dis; 2012 Apr; 18(4):603-12. PubMed ID: 21887730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO.
    Abbott DW; Wilkins A; Asara JM; Cantley LC
    Curr Biol; 2004 Dec; 14(24):2217-27. PubMed ID: 15620648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression.
    Wehkamp J; Harder J; Weichenthal M; Schwab M; Schäffeler E; Schlee M; Herrlinger KR; Stallmach A; Noack F; Fritz P; Schröder JM; Bevins CL; Fellermann K; Stange EF
    Gut; 2004 Nov; 53(11):1658-64. PubMed ID: 15479689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal alpha-defensin expression in pediatric inflammatory bowel disease.
    Zilbauer M; Jenke A; Wenzel G; Goedde D; Postberg J; Phillips AD; Lucas M; Noble-Jamieson G; Torrente F; Salvestrini C; Heuschkel R; Wirth S
    Inflamm Bowel Dis; 2011 Oct; 17(10):2076-86. PubMed ID: 21910169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOD2 Is Regulated By Mir-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease.
    Pierdomenico M; Cesi V; Cucchiara S; Vitali R; Prete E; Costanzo M; Aloi M; Oliva S; Stronati L
    Inflamm Bowel Dis; 2016 Feb; 22(2):315-26. PubMed ID: 26752466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIP2 filament formation is required for NOD2 dependent NF-κB signalling.
    Pellegrini E; Desfosses A; Wallmann A; Schulze WM; Rehbein K; Mas P; Signor L; Gaudon S; Zenkeviciute G; Hons M; Malet H; Gutsche I; Sachse C; Schoehn G; Oschkinat H; Cusack S
    Nat Commun; 2018 Oct; 9(1):4043. PubMed ID: 30279485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XIAP mediates NOD signaling via interaction with RIP2.
    Krieg A; Correa RG; Garrison JB; Le Negrate G; Welsh K; Huang Z; Knoefel WT; Reed JC
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14524-9. PubMed ID: 19667203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDP-NOD2 stimulation induces HNP-1 secretion, which contributes to NOD2 antibacterial function.
    Yamamoto-Furusho JK; Barnich N; Hisamatsu T; Podolsky DK
    Inflamm Bowel Dis; 2010 May; 16(5):736-42. PubMed ID: 19856414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The c-Jun N-terminal kinase (JNK)-binding protein (JNKBP1) acts as a negative regulator of NOD2 protein signaling by inhibiting its oligomerization process.
    Lecat A; Di Valentin E; Somja J; Jourdan S; Fillet M; Kufer TA; Habraken Y; Sadzot C; Louis E; Delvenne P; Piette J; Legrand-Poels S
    J Biol Chem; 2012 Aug; 287(35):29213-26. PubMed ID: 22700971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains.
    Abbott DW; Yang Y; Hutti JE; Madhavarapu S; Kelliher MA; Cantley LC
    Mol Cell Biol; 2007 Sep; 27(17):6012-25. PubMed ID: 17562858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation.
    Hasegawa M; Fujimoto Y; Lucas PC; Nakano H; Fukase K; Núñez G; Inohara N
    EMBO J; 2008 Jan; 27(2):373-83. PubMed ID: 18079694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of innate immunity genes in different intestinal sites of children with ulcerative colitis.
    Stronati L; Negroni A; Pierdomenico M; D'Ottavio C; Tirindelli D; Di Nardo G; Oliva S; Viola F; Cucchiara S
    Dig Liver Dis; 2010 Dec; 42(12):848-53. PubMed ID: 20452301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
    Strober W; Asano N; Fuss I; Kitani A; Watanabe T
    Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective paneth cell-mediated host defense in pediatric ileal Crohn's disease.
    Perminow G; Beisner J; Koslowski M; Lyckander LG; Stange E; Vatn MH; Wehkamp J
    Am J Gastroenterol; 2010 Feb; 105(2):452-9. PubMed ID: 19904243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.